(Bloomberg) -- Google offers its full-time employees working from home a supply of high-end instant Covid-19 tests. Meanwhile, the contract workers still coming into offices have to wait longer for results.Most Read from BloombergCannabis Compounds Prevented Covid Infection in Laboratory StudyDirecTV to Drop One America News in Blow to Conservative ChannelCovid Pandemic May Shift to Endemic in 2022, Moderna Chair SaysScientists Discover Gene That Increases Risk of Dying From CovidFrequent Booste
SAN DIEGO, January 11, 2022--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, ("Cue’) today reported preliminary unaudited revenue for fourth quarter and full year 2021.
Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced it will develop an Omicron-Genotyping COVID-19 test to be used in professional point-of-care settings as part of the company's ongoing work with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response. The Omicron-specific test will complement Cue's existing highly-accurate, molecula